A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma

Laurens E. Franssen,Mieke W.H. Roeven,Willemijn Hobo,Ruud Doorn,Rimke Oostvogels,J.H.F. Falkenburg,N.W.C.J. van de Donk,Michel G.D. Kester,Hanny Fredrix,Kasper Westinga,Ineke Slaper-Cortenbach,Eric Spierings,Marie José Kersten,Harry Dolstra,Tuna Mutis,Nicolaas Schaap,Henk M. Lokhorst

A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma

2017

Laurens E. Franssen
Mieke W.H. Roeven
Willemijn Hobo
Ruud Doorn
Rimke Oostvogels
J.H.F. Falkenburg
N.W.C.J. van de Donk
Michel G.D. Kester
Hanny Fredrix
Kasper Westinga
Ineke Slaper-Cortenbach
Eric Spierings
Marie José Kersten
Harry Dolstra
Tuna Mutis
Nicolaas Schaap
Henk M. Lokhorst

A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma

Keywords:

Lymphocyte
Immunology
Minor histocompatibility antigen
Dendritic cell
Progenitor cell
Medicine
Transplantation
Graft-versus-host disease
Stem cell
Histocompatibility
CD8
Multiple myeloma
Lymphocyte Transfusion

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations